[
  {
    "report_key": "2026:q2",
    "period_label": "2026 Q2",
    "date": "2026-07-14",
    "title": "Kvartalsrapport Q2 2026",
    "original_title": "Delårsrapport januari - juni 2026",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b0b5abbcfdd4cd40798dae4c97bcff593&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
        "title": "Kvartalsrapport Q2 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a0680c241d076247be055e08da27e968d",
        "date": "2026-07-14",
        "period": "2026-q2",
        "form_type": "interim-report",
        "report_key": "2026:q2",
        "filename": "XVIVO_Delarsrapport_Januari_Juni_2026.pdf",
        "text_chars": 79405,
        "sha256": "8bffac95165c5c8b26a6ba714b0d207045823072c1bdc2848938ba7a2f567499",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
            "chars": 79405
          }
        ]
      }
    ],
    "alternatives": [
      {
        "source": "MFN fallback",
        "language": "sv",
        "title": "Delårsrapport januari - juni 2026",
        "release_url": "https://mfn.se/a/xvivo-perfusion/delarsrapport-januari-juni-2026"
      },
      {
        "source": "MFN fallback",
        "language": "sv",
        "title": "Telefonkonferens avseende delårsrapport april-juni 2026",
        "release_url": "https://mfn.se/a/xvivo-perfusion/telefonkonferens-avseende-delarsrapport-april-juni-2026"
      }
    ]
  },
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-04-24",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "Delårsrapport januari - mars 2026",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=baa5bcbc3fc307ce23f0fdb57d979b599&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a941583dc581b0dbcdcc0aea16c08ba15",
        "date": "2026-04-24",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "XVIVO_Delarsrapport_Q1_2026.pdf",
        "text_chars": 68483,
        "sha256": "078f9acc5643a946b13bcf798e7c5bdb9f62511784342e23069ab0140b8888ce",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 68483
          }
        ]
      }
    ],
    "alternatives": [
      {
        "source": "MFN fallback",
        "language": "sv",
        "title": "Delårsrapport januari - mars 2026",
        "release_url": "https://mfn.se/a/xvivo-perfusion/delarsrapport-januari-mars-2026"
      },
      {
        "source": "MFN fallback",
        "language": "sv",
        "title": "Telefonkonferens avseende delårsrapport januari-mars 2026",
        "release_url": "https://mfn.se/a/xvivo-perfusion/telefonkonferens-avseende-delarsrapport-januari-mars-2026"
      }
    ]
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-04-01",
    "title": "Årsredovisning 2025",
    "original_title": "Årsredovisning 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7bdf0373745ab8206612b6c745615d4e&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a615f74af236f4a6f9efc8f84ec007fd2",
        "date": "2026-04-01",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "XVIVO_Perfusion_Ab_publ_Arsredovisning_2025.pdf",
        "text_chars": 297663,
        "sha256": "32699933fab9b80e4730f5b5cbafc1a712cdd995bc233a139d2d379038636a3d",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 179473
          },
          {
            "number": 2,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
            "chars": 118188
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-01-27",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "Bokslutskommuniké 2025",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bbf1e323680987107e9ade3e78893dd7b&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aab3317c3c213f82c4959f115aec7047b",
        "date": "2026-01-27",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "XVIVO_Bokslutskommunike_2025.pdf",
        "text_chars": 84932,
        "sha256": "be70920de31e7ac3a3e270360657c3be51e0ce8aff4d9076895aaafd02388adf",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 84932
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-10-23",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "Delårsrapport januari - september 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bb846263b20d9eb4e5735e73b7f34e05c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a6083fd0d00915dbdf5eb7c7061d09e71",
        "date": "2025-10-23",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "XVIVO_Delarsrapport_Q3_2025.pdf",
        "text_chars": 88291,
        "sha256": "4c2f06df608966130ce293f0bf24c6ded2a92cdad0c28e048797bd1fc616aaf2",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
            "chars": 88291
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-07-11",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "Delårsrapport januari-juni 2025",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b5e08de572f10d1b46f1f1504c3ed95ca&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ac2517d0001a6275598b4a18f26df418f",
        "date": "2025-07-11",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "XVIVO_Delarsrapport_Q2_2025.pdf",
        "text_chars": 83790,
        "sha256": "9ca6c576f22c5d350885f34533cf2db39c3cd319d9ff9ef814cedf466f94ba27",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 83790
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-04-24",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "Delårsrapport januari-mars 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bf195a344a886c58b9323b9e085ea0189&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a0630e41971a7e7f83d3e62a07a7dd3b4",
        "date": "2025-04-24",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "XVIVO_Delarsrapport_Q1_2025.pdf",
        "text_chars": 70692,
        "sha256": "58b696e541849758b47240a3be059d9cee3d470c19393430a39a15701c5de5a0",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
            "chars": 70692
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-04-02",
    "title": "Årsredovisning 2024",
    "original_title": "Årsredovisning 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b038f773b17cd4567da77aeb392d6fe21&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a479f81637801444ef3fec443441821b6",
        "date": "2025-04-02",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "XVIVO_Perfusion_AB_publ_Arsredovisning_2024.pdf",
        "text_chars": 309968,
        "sha256": "e009304fe3af6debb56cf1237544516db5b42015773d9272b02295c98cd55975",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 178215
          },
          {
            "number": 2,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
            "chars": 131751
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-01-28",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "Bokslutskommuniké 2024",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4a0c118a9f163b9f0d600cee15ee0e45&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a3fca5cd2988e9f95e40dcea4b9ae30c1",
        "date": "2025-01-28",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "XVIVO_Bokslutskommunike_2024.pdf",
        "text_chars": 98297,
        "sha256": "18d8631ba7e30d2b81ea8cbe5d327551e3a610d98a87d0f1098e0553a520d40c",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 98297
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q3",
    "period_label": "2024 Q3",
    "date": "2024-10-24",
    "title": "Kvartalsrapport Q3 2024",
    "original_title": "Delårsrapport januari-september 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b9d7a92cabb120715b62146a39a9c4dd9&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
        "title": "Kvartalsrapport Q3 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aafd86ee6455d0f214bead4e7b87db27d",
        "date": "2024-10-24",
        "period": "2024-q3",
        "form_type": "interim-report",
        "report_key": "2024:q3",
        "filename": "XVIVO_Delarsrapport_Januari_September_2024.pdf",
        "text_chars": 93302,
        "sha256": "6d244769370a20ed82430da4bf230cb52faf47597c0a042d254b43e919d65117",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
            "chars": 93302
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-07-12",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "Delårsrapport januari - juni 2024",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=be961082034cceda71a6bd987a87c6201&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ae4bc39452b8c18d57d41d1a3d79b4dd3",
        "date": "2024-07-12",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "XVIVO_Delarsrapport_Q2_2024.pdf",
        "text_chars": 84644,
        "sha256": "c8646a6f2eeaf79da17e0c576eb1caaa49ef7226b8b46765c02aa7700fada482",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 84644
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q1",
    "period_label": "2024 Q1",
    "date": "2024-04-24",
    "title": "Kvartalsrapport Q1 2024",
    "original_title": "Delårsrapport januari-mars 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4f1d0d88309037de861a05447499097e&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
        "title": "Kvartalsrapport Q1 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/afd08b19f207c3c067419219657cee68a",
        "date": "2024-04-24",
        "period": "2024-q1",
        "form_type": "interim-report",
        "report_key": "2024:q1",
        "filename": "XVIVO_Delarsrapport_Q1_2024.pdf",
        "text_chars": 73866,
        "sha256": "07e7c535f884c16dcee0b372ced28af7741716c998b9b8288ffd6d6d277a0c87",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
            "chars": 73866
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-04-04",
    "title": "Årsredovisning 2023",
    "original_title": "Årsredovisning 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b27aec971d18b8113be546f58ba6a73c3&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/adb17d80609340e8198aeadcdb3edac22",
        "date": "2024-04-04",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "XVIVO_Perfusion_AB_publ_Arsredovisning_2023.pdf",
        "text_chars": 328330,
        "sha256": "a966b828525b8879f5bce518b9e132e61bbb641a3d838f80a85244b8ac8c5acb",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 176290
          },
          {
            "number": 2,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
            "chars": 152038
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-01-25",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "XVIVO avlämnar Bokslutskommuniké 2023",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=ba63cd9fd99559986b54b95d5b2a3b032&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a9f7506bf556d77c16fc28778ffd31219",
        "date": "2024-01-25",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "XVIVO_Bokslutskommunike_2023.pdf",
        "text_chars": 102592,
        "sha256": "0c2d8c4e7dfaee195a580c9dabbcf0996d49aa0f4fc6e7c5563dc388014a2c3a",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 102592
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q3",
    "period_label": "2023 Q3",
    "date": "2023-10-24",
    "title": "Kvartalsrapport Q3 2023",
    "original_title": "Delårsrapport januari-September 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4caeb20a26fd9f1b2dfaad1117675c68&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
        "title": "Kvartalsrapport Q3 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a945137115ed567efad38b5e038ff0c75",
        "date": "2023-10-24",
        "period": "2023-q3",
        "form_type": "interim-report",
        "report_key": "2023:q3",
        "filename": "XVIVO_Delarsrapport_Januari_September_2023.pdf",
        "text_chars": 97520,
        "sha256": "6f9acea7642de192e012480e7d1d576d625601d3911a15461a49342a64288a45",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
            "chars": 97520
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-07-13",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "XVIVO avlämnar delårsrapport januari-juni 2023",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bcc1abc698b1d0ec4edb416453c715854&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a07f7d275af50fb575d75dd0872902212",
        "date": "2023-07-13",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "XVIVO_Delarsrapport_Januari_Juni_2023.pdf",
        "text_chars": 88874,
        "sha256": "a9fb480625eb2301c97255699c01b78794f8c9d63c2c0c9f534a23378ec8d359",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 88874
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q1",
    "period_label": "2023 Q1",
    "date": "2023-04-24",
    "title": "Kvartalsrapport Q1 2023",
    "original_title": "XVIVO avlämnar delårsrapport januari-mars 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=ba839d0df61e44949f3a88008d3e007b3&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
        "title": "Kvartalsrapport Q1 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a01a8f1549d0c7ef8ac32bacf15691322",
        "date": "2023-04-24",
        "period": "2023-q1",
        "form_type": "interim-report",
        "report_key": "2023:q1",
        "filename": "XVIVO_Delarsrapport_Q1_2023.pdf",
        "text_chars": 71155,
        "sha256": "52cffa027d836b5446c9f546895c872a7b1d3b202caf8749688a45ae46a10345",
        "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "absolute_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "txt_url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
            "chars": 71155
          }
        ]
      }
    ],
    "alternatives": []
  }
]